Marty Makary's Resignation Highlights FDA's Leadership Woes
Marty Makary's recent resignation from the FDA underscores persistent leadership challenges and political pressures facing the agency.
FDA
Recent coverage
From the wire
STAT+: FDA drug center head Tracy Beth Høeg leaves as agency faces leadership vacuum
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
CDER chief Høeg expected to leave FDA, according to source
Candel reports prostate cancer drug's long-term data ahead of FDA filing
FDA’s leadership void leaves biotech with renewed ‘uncertainty’
STAT+: A political contest in the U.K. could shake up drug pricing
With new data, Regenxbio to seek FDA approval of Duchenne gene therapy
Half of AI Health Advice Is Wrong—And Seems Just Right